Links

Tools

Export citation

Search in Google Scholar

Economic evaluation of brentuximab vedotinin patients older that 18 years with recurrent or refractory CD30+ systemic anaplastic large-cell lymphoma

Journal article published in 2016 by A. S. Kolbin ORCID, I. A. Vilum, M. A. Proskurin, Yu E. Balykina
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Upload
Question mark in circle
Postprint: policy unknown
Upload
Question mark in circle
Published version: policy unknown
Upload